Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Expects STD Claims Enforcement To Deter Future Violations

This article was originally published in The Tan Sheet

Executive Summary

FDA will consider prosecuting executives of firms making unapproved sexually transmitted disease treatment claims for OTC drugs and nutritional products, the targets of its latest enforcement sweep.

You may also be interested in...

DoJ Casts Criminal Charge Net For Supplements Making STD Claims

DoJ announces misdemeanor charges against firm warned about making unapproved claims of treating STDs and cancer for products marketed as dietary supplements, while FDA continues finding the banned weight loss drug sibutramine in products.

Criminal Charges Against Hoodia Suppliers, Consent Decree For Herpes Claim Firm

Diverting PSE for meth among four criminal charges against N.J. firms also marketing adulterated hoodia; and complaint on Florida firm's STD claims comes four years after warning about possible prosecutions.

Tracking Federal Agencies’ Enforcement In Supplement Space

““The Tan Sheet” provides links to previous articles on many of the enforcements DoJ announced from its year-long sweep.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts